Evommune, Inc. · NYSE:EVMN
Andera Partners's stake in Evommune, Inc. fell to 3.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Andera Partners's stake in Evommune, Inc. fell to 3.90%, 1,391,990 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 3.90%
- Shares
- 1,391,990
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Andera Partners | 3.90% | 1,391,990 |
| BioDiscovery 6 FPCI | 3.90% | 1,391,990 |
| Stephane Bergez | 3.90% | 1,391,990 |
| Francois Xavier Mauron | 3.90% | 1,391,990 |
Source
Related
- Evommune, Inc.
- Andera Partners
- Evommune, Inc. shareholders
- Schedule 13G · Andera Partners · Nov 17, 2025
- Form 4 · Pena Luis C. · Oct 15, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jul 16, 2026
- Form 4 · Carver Kyle · Jul 10, 2026
- Form 4 · Kirsch Arthur S · Jul 8, 2026